/KASE, November 3, 2017/ – Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has notified KASE of a KZT350,647,413.51 loan received on November 1, 2017 (in Kazakh and Russian) – see more

[2017-11-03]